Farmer, who has conducted research regarding the usability of at-home medical technologies, spoke to the potential impact of the approval and wider use of Covid-19 tests that could be performed in homes, rather than at testing sites.
Excerpt:
]]>For months, Georgia Tech researchers have been studying usability and accuracy of most home tests seeking FDA approval.
That includes the one from the Australian company Ellume. The U.S. just announced a $231 million deal with Ellume to buy 8.5 million tests by the end of the year.
“It’s the convenience, it’s the turnaround time. Hopefully there will be more widespread testing. People will maybe be able to test themselves more frequently,” Farmer said.